AU2327692A - Box-based composition for treating hiv (human immunodeficiency virus) infection - Google Patents

Box-based composition for treating hiv (human immunodeficiency virus) infection

Info

Publication number
AU2327692A
AU2327692A AU23276/92A AU2327692A AU2327692A AU 2327692 A AU2327692 A AU 2327692A AU 23276/92 A AU23276/92 A AU 23276/92A AU 2327692 A AU2327692 A AU 2327692A AU 2327692 A AU2327692 A AU 2327692A
Authority
AU
Australia
Prior art keywords
box
infection
composition
immunodeficiency virus
human immunodeficiency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23276/92A
Inventor
Pierre Dellamonica
Jacques Durant
Alain Rebouillat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite de Nice Sophia Antipolis UNSA
Original Assignee
Universite de Nice Sophia Antipolis UNSA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite de Nice Sophia Antipolis UNSA filed Critical Universite de Nice Sophia Antipolis UNSA
Publication of AU2327692A publication Critical patent/AU2327692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A box-based composition for treating acquired immunodeficiency syndrome (AIDS) and patients who are seropositive for this retrovirus and similar syndromes. The composition for treating immunodeficiency by correcting the currently used parameters for defining this disease is characterized in that it uses a plant from the box family. Said composition essentially consists of steroid alkaloids which are specific to the box family and derived from cycloartenol, i.e. cyclobuxine D, buxamine in particular and other compounds. The composition is useful for treating HIV (human immunodeficiency virus) infection and TNF-related diseases.
AU23276/92A 1991-07-10 1992-07-03 Box-based composition for treating hiv (human immunodeficiency virus) infection Abandoned AU2327692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9108790A FR2678835B1 (en) 1991-07-10 1991-07-10 BUIS-BASED COMPOSITION FOR THE TREATMENT OF HIV INFECTION (HUMAN IMMUNODEFISCIENCE VIRUS).
FR9108790 1991-07-10

Publications (1)

Publication Number Publication Date
AU2327692A true AU2327692A (en) 1993-02-11

Family

ID=9415025

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23276/92A Abandoned AU2327692A (en) 1991-07-10 1992-07-03 Box-based composition for treating hiv (human immunodeficiency virus) infection

Country Status (7)

Country Link
EP (1) EP0600915B1 (en)
AT (1) ATE160091T1 (en)
AU (1) AU2327692A (en)
DE (1) DE69223152T2 (en)
ES (1) ES2112324T3 (en)
FR (1) FR2678835B1 (en)
WO (1) WO1993000916A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2716805B1 (en) * 1994-03-04 1996-05-24 Nice Sophia Antipolis Universi Immunomodulatory composition useful in particular for the treatment of infections caused by HIV.
FR2769840A1 (en) * 1997-10-17 1999-04-23 Pierre Dellamonica Buxus sempervirens extract as a source of alkaloids
RU2494588C1 (en) * 2012-05-24 2013-10-10 Государственное научное учреждение Всероссийский научно-исследовательский технологический институт ремонта и эксплуатации машинно-тракторного парка Российской академии сельскохозяйственных наук (ГНУ ГОСНИТИ Россельхозакадемия) Plough share

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB782469A (en) * 1954-07-14 1957-09-04 Merck & Co Inc Anti-t.b. factor

Also Published As

Publication number Publication date
FR2678835A1 (en) 1993-01-15
EP0600915A1 (en) 1994-06-15
DE69223152D1 (en) 1997-12-18
WO1993000916A1 (en) 1993-01-21
DE69223152T2 (en) 1998-06-18
ES2112324T3 (en) 1998-04-01
ATE160091T1 (en) 1997-11-15
EP0600915B1 (en) 1997-11-12
FR2678835B1 (en) 1995-05-24

Similar Documents

Publication Publication Date Title
Centers for Disease Control (CDC Update: transmission of HIV infection during invasive dental procedures--Florida
HUP0500558A2 (en) Low dose entecavir formulation and process for its preparation
UA29429C2 (en) Pharmaceutical composition for treatment of viral infections, method for preparation of composition, method for treatment or prophylaxis of aids in human
WO1988009181A3 (en) Monoclonal antibodies neutralizing hiv-1
AP2000001991A0 (en) 3-(Amino-or aminoalkyl) pyridinone derivatives and their use for the treatment of HIV related diseases.
BR0317230A (en) Compound, composition, methods of antagonizing a ccr-5 chemokine receptor activity, and treating a viral infection in a patient, and use of a compound
NZ335612A (en) A composition containing cytotoxic specificT-cell epitopes being either Rev and/or Tat proteins from HIV virus for prevention and treatment of human immunodeficiency virus (HIV) infection
YU27203A (en) Pyrazole derivatives for the treatment of viral diseases
WO2001078648A3 (en) 6-methylnicotinamide derivatives as antiviral agents
MY126450A (en) Crystalline efavirenz
AU1226288A (en) Processes for the preparation of medicinal compositions, compositions obtained by these processes and use thereof for the preparation of medicines against viral hepatitis b and acquired immunodeficiency syndrome
AU4001289A (en) Heparin fragments and fractions with anti-hiv action
AU2327692A (en) Box-based composition for treating hiv (human immunodeficiency virus) infection
HUT52957A (en) Process for production of combined medical compositions
GR3024226T3 (en) Antiviral naphthoquinone compounds, compositions and uses thereof.
IL115074A0 (en) A novel salt of (1s,4r)-cis-4--Ú2-amino-6-(cyclopropylamino)-9h-purin-9-yl-¾- 2-cyclopentene-1-methanol solvates thereof their preparation and pharmaceutical compositions containing them
ATE213231T1 (en) MICHELLAMINE FOR USE AS ANTIVIRAL INGREDIENTS, COMPOSITION AND METHOD OF TREATMENT
CA2237194A1 (en) Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants
AU4111600A (en) The use of gssg reductase for the therapy and prophylaxis of hiv infected patients
IL102815A (en) Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus
ES469020A1 (en) N1-acyl-N2-phenyldiaminopropanols and pharmaceutical compositions thereof
IL139360A0 (en) Viral chimeras comprised of caev and hiv-1 genetic elements
WO1993014760A3 (en) Methods
Dalcolmo Tuberculosis and HIV infection in Brazil--update and overview
CA2220347A1 (en) Compositions and methods for detecting and treating acquired immunodeficiency syndrome